| Literature DB >> 34974841 |
Davina Allen1, Amy Lloyd2, Dawn Edwards3, Kerenza Hood2, Chao Huang4, Jacqueline Hughes2, Nina Jacob2, David Lacy5, Yvonne Moriarty2, Alison Oliver6, Jennifer Preston7, Gerri Sefton8, Ian Sinha, Richard Skone6, Heather Strange2, Khadijeh Taiyari2, Emma Thomas-Jones2, Rob Trubey2, Lyvonne Tume9, Colin Powell10,11, Damian Roland12,13.
Abstract
BACKGROUND: Paediatric mortality rates in the United Kingdom are amongst the highest in Europe. Clinically missed deterioration is a contributory factor. Evidence to support any single intervention to address this problem is limited, but a cumulative body of research highlights the need for a systems approach.Entities:
Keywords: Healthcare improvement; Paediatric early warning systems; Quality improvement
Mesh:
Substances:
Year: 2022 PMID: 34974841 PMCID: PMC8722056 DOI: 10.1186/s12913-021-07314-2
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
The OUTCOME Framework: principles, structures, theory, and application in the PUMA study
| PRINCIPLES | STRUCTURES | THEORY | PUMA |
|---|---|---|---|
| Outcome-directed | |||
| Improvement is directed towards achieving an agreed outcome or goal | Specification of the collective action to be targeted for improvement and its overarching goal. | TMT | The goal of the PUMA study was to improve collective action in relation to the afferent component of a paediatric early warning system, which detects deterioration and triggers timely and appropriate action, and excluded the efferent component, which consists of the people and resources providing a response |
| Functions-oriented | |||
| Improvement is oriented towards the functions necessary to achieve the goal | Specification of the core components, mechanisms of action and their relationships necessary to achieve the overarching goal. | TMT | Collective action in detecting and acting in response to deterioration includes detection (monitoring, recording, interpreting), preparation (reviewing, planning) and action (escalation, evaluation). |
| System-focused | |||
| Improvement is focused on the socio-material system required to enact the functions necessary to achieving the goal | Minimum standards required to achieve the goal across contexts are specified (e.g. socio-material resources - people, materials, knowledge, processes and mechanisms) | TMT | In PUMA the minimal standards for a system for detecting acting on deterioration was specified in propositional model structured around the 7 core functions |
| Context-specific | |||
| Improvement is focused on the development of locally appropriate initiatives to achieve the goals | Tools developed to assess systems against the standard | TMT/NPT | Staff System Assessment Tool Family Feedback Tool |
| Locally–led | |||
| Improvement capitalises on the expertise and knowledge of those delivering services | Five step process to support improvement: 1) Form an improvement team 2) Assess the system 3) Select and plan improvement initiatives 4) Implement and review initiatives 5) Sustain progress | NPT Model for Improvement. | Improvement guide Structured facilitation On-going support |
| Learning systems | |||
| Improvement is sustained by the creation of a learning system to optimise outcomes through the application of system assessment tools, to keep systems under review, and structures for supporting local leadership. | System Assessment Tools to enable reflexive monitoring Framework to support improvement process drawn from the Model for Improvement. | TMT NPT | Improvement Guide provided guidance on repeating the system assessment every 12–24 months to reflexively monitor performance, select and plan initiatives and implement and review initiatives. |
Summary of Study Sites
| Site 1 | Site 2 | Site 3 | Site 4 | |
|---|---|---|---|---|
| Tertiary | District General | Tertiary | District General | |
| Yes | Yes | No | No | |
| Yes | No | Yes | No | |
| 12 | 1 | 8 | 2 | |
| 337 in-patients, 15 HDU | 32 in-patient, 2 HDU | 61 in-patient, 4 HDU | 38 in-patient, 7 HDU | |
| Cardiac medical/surgical and neonatal | General paediatric (might want to specify medical/surgical) | Medical | Medical |
Qualitative data collection for each case study
| Site | Pre-implementation data collection | Post-implementation data collection |
|---|---|---|
| Site 1 | •-54 h of observation •-8 x staff interviews •-13 x family/carer interviews | •-58 h of observation •-13 x staff interviews •-7 x family/carer interviews |
| Site 2 | •-44 h of observation •-13 x staff interviews •-10 x family/carer interviews | •-53 h of observation •-19 x staff interviews •-9 x family/carer interviews |
| Site 3 | •-78 h of observation •-15 x staff interviews •-8 x family/carer interviews | •-51 h of observation •-11 x staff interviews •-10 x family/carer interviews |
| Site 4 | •-70 h of observation •-17 x staff interviews •-7 x family/carer interviews | •-38 h of observation •-23 x staff interviews •-10 x family/carer interviews |
Fig. 1The core components of a paediatric early warning system: the puma standard
Fig. 2The core components of a paediatric early warning system: the puma wheel
Summary of support and resources provided for each of the five improvement steps
| Improvement Step | Facilitated workshop | Materials and resources provided to PIs | Additional facilitation strategies |
|---|---|---|---|
| 1. Form an improvement team | ‘Set-up’ session | Instructions and worksheets Power Point slides to introduce PUMA to others | Implementation support phone calls between site PIs and PUMA study researcher (offered fortnightly) |
| 2. Assess the system | ‘Set-up’ session | Instructions and worksheets PUMA Standard and PUMA wheel PUMA system assessment tools (SSAT and FFT) | Implementation support phone calls between site PIs and PUMA study researcher (offered fortnightly) |
| 3. Select and plan improvement initiatives | ‘Action planning’ session | Instructions and worksheets | Implementation support phone calls between site PIs and PUMA study researcher (offered fortnightly) |
| 4. Implement and review initiatives | ‘Action planning’ session | Instructions and worksheets | Implementation support phone calls between site PIs and PUMA study researcher (offered fortnightly) Implementation support meetings (phone and face to face) between site PIs and PUMA study team |
| 5. Sustain Progress | Instructions |
Fig. 3Strengths and weakness of paediatric early warning systems pre-implementation
Summary of embedded site initiatives against the PUMA Standard
| Proposition | Site 1 initiatives | Site 2 initiatives | Site 3 initiatives | Site 4 initiatives | |
|---|---|---|---|---|---|
| Detection of deterioration depends on timely and appropriate | 1. Developed a tool to encourage family engagement 2. Retraining on recognition and response to deterioration including NICE sepsis screening for front-line clinical staff | No relevant initiative | No relevant initiative | 1. Observation policy updated and disseminated 2. Posters and cards for staff used to signpost abnormal thresholds for vital signs 3. Observation charts updated to include normal age-related thresholds disseminated 4. Inventory of equipment conducted | |
| Planning depends on | 3. Implemented standard operating procedures (SOP) for out of hours working for on-call medical teams – prioritising sickest children (hospital-wide) | 1. Initially planned to introduce second daily huddle, but it was not deemed possible. More frequent telephone calls between the ward and Paediatric Assessment Unit (PAU) introduced and the two areas now share a rotation of Band 6 nurses. A safety huddle takes place at 9 am on the main ward now seems to have taken on the momentum for addressing what the second daily huddle initially set out to do. 2. Initially planned joint handover sheets, using Situation Background Assessment Recommendation (SBAR), but was not deemed possible. Nurses’ handover sheet changed to SBAR. | 1. Introduced site board to display ‘4Ss’ (sickest patients, bed status, safeguarding issues and staffing). 2. Senior nurses now phone through to doctors’ handover if they have any concerns about a particular patient | 5. Plans to establish a staff training course on situational awareness were amended; situational awareness now included in statutory training days | |
| Action depends on clear | 3. Introduction of new escalation policy | 6. Escalation policy reviewed and disseminated |
Contextual factors impacting on paediatric early warning systems during implementation
| Site 1 | Site 2 | Site 3 | Site 4 | |
|---|---|---|---|---|
| ·Response to critical incident and CQC inspections led to several trust-mandated changes (see non-PUMA initiatives) | Nothing to report | Study Chief Investigator with senior clinical position at site left post (no longer present as reminder to frontline staff of PUMA/associated initiatives) · High level of staff turnover · Changes to PICU and HDU admissions thresholds – increased likelihood of admission/referral | Hospital involved in wider organisational-level restructuring; some impact on initiatives which required governance and institutional approvals. | |
· Increase in number of qualified nursing staff · Loss of some experienced nursing staff · Introduction of consistent 24/7 band 6/shift coordinator cover · Additional, more effective mobile computers · 2 senior nurses training to become ANPs | · New manager joins ward and reduces HDU transfers, through greater focus on needs of individual patient rather than care plan. Many patients who would previously have been admitted to HDU cared for on the ward | · Nursing handover/team organisation changed; nurses allocated to one section of ward, received handover for patients in that section only · ANPs no longer included within medical team · Medical team increased from 8 to 10-person rota, increased capacity to cope with sickness/training absence · Improvements to monitoring equipment; additional Optiflows & saturation monitors, central monitoring station. | Nothing to report | |
| Nothing to report | · Loss experienced nursing staff · Increase in number of band 6 nurses · Increased use of agency staff | Nothing to report | Nothing to report |
Fig. 4Strengths and weakness of paediatric early warning systems post-implementation
Positive and negative changes to paediatric early warning system - post implementation
| Site 1 | Site 2 | Site 3 | Site 4 | |
|---|---|---|---|---|
| Detect | ||||
| Plan | ||||
| Act |
Fig. 5Scatter plots for primary outcome in each of the four sites with fitted line from segmented linear regression
Estimates from segmented linear regression for adverse events in Site 1
| Outcome | Estimate, ß | Interpretation | |
|---|---|---|---|
| Adverse events | |||
| Intercept | 3.08 (2.93, 3.24) | < 0.00001 | |
| Pre-intervention trend | 0.02 (0.00, 0.03) | 0.04 | Adverse events were very gradually but significantly increasing during this period. Given the low overall rates the clinical impact of this increase is difficult to determine. |
| Change in slope (implementation period vs. pre-intervention period) | 0.03 (−0.03, 0.09) | 0.29 | There was a trend towards an increasing rate of adverse events (against the expected trend) but this was not significant. The wide confidence intervals mean the trend could have been in either direction should a greater sample size have been available. |
| Immediate change in level (implementation period vs. pre-intervention period) | 0.15 (− 0.34, 0.64) | 0.55 | |
| Change in slope (post-intervention period vs. implementation period) | -0.09 (−0.15, − 0.05) | < 0.001 | Adverse event rates decreased by nearly 10% in this period, compared to the implementation period, which was statistically significant. |
| Immediate change in level (post-intervention period vs. implementation period) | −0.43 (−1.03, 0.17) | 0.16 | |
Estimates from segmented linear regression for adverse events in Site 2
| Outcome | Estimate, ß | Interpretation | |
|---|---|---|---|
| Adverse events | |||
| Intercept | 3.08 (2.93, 3.24) | ||
| Pre-intervention trend | −0.17 (− 0.49, 0.17) | 0.29 | There is a trend (non-significant) for reducing events but the paucity of them occurring (in relation to raw numbers) makes it difficult to draw concrete conclusions. |
| Change in slope (implementation period vs. pre-intervention period) | 0.02 (−0.30, 0.33) | 0.98 | The trend does not appear to change but the confidence limits around this are large. |
| Immediate change in level (implementation period vs. pre-intervention period) | 0.29 (−1.74, 2.32) | 0.78 | |
Estimate from segmented linear regression for adverse events in Site 3
| Outcome | Estimate, ß | Interpretation | |
|---|---|---|---|
| Adverse events | |||
| Intercept | 3.27 (2.12, 4.42) | ||
| Pre-intervention trend | 0.04 (−0.06, 0.15) | 0.42 | There is a trend towards increasing event rates although this is not significant. |
| Change in slope (implementation period vs. pre-intervention period) | 0.01 (−0.16, 0.18) | 0.92 | The event rate doesn’t change but given the wide confidence intervals it is difficult to be precise about whether this is a true effect. |
| Immediate change in level (implementation period vs. pre-intervention period) | 0.21 (−1.55, 1.97) | 0.81 | |
| Change in slope (post-intervention period vs implementation period) | −0.27 (− 0.47, − 0.07) | 0.01 | The trend significantly reduced over this period (although the overall number of events per patients day increases) |
| Immediate change in level (post-intervention period vs. implementation period) | 1.98 (−0.22, 4.18) | 0.09 | |
Estimates from segmented linear regression for adverse events in Site 4
| Outcome | Estimate, ß | Interpretation | |
|---|---|---|---|
| Adverse events | |||
| Intercept | 29.69 (26.89, 32.49) | ||
| Pre-intervention trend | −0.10 (−0.40, 0.21) | 0.55 | There was no apparent significant trend in the overall adverse event rate. |
| Change in slope (implementation phase vs pre-intervention phase) | −0.64 (−1.15, − 0.13) | 0.02 | There was a significant deviation in the event rate during the implementation phase which probably represents a real clinical impact. |
| Immediate change in level (implementation period vs. pre-intervention period) | 1.57 (−4.05, 7.18) | 0.59 | |
| Change in slope (post-intervention phase vs implementation phase) | 0.32 (−0.29, 0.93) | 0.31 | This trend was maintained but was not significantly different from the implementation phase. |
| Immediate change in level (post-intervention period vs. implementation period) | 0.32 (−0.29, 0.93) | 0.31 | |